A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
It is produced by the strain of Streptomyces caespitosus var. detoxicus 7072 GCl and Str. mobaraensis. Synonyms: Detoxin calpha1; Detoxin C1 [MI]; L-Phenylalanine, N-acetyl-, (1S)-1-((2S,3R)-3-(acetyloxy)-1-((2S)-2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-2-carboxyethyl ester. CAS No. 74717-53-6. Molecular formula: C25H35N3O8. Mole weight: 505.56.
Detoxin D1
It is produced by the strain of Streptomyces caespitosus var. detoxicus 7072 GCl and Str. mobaraensis. Synonyms: Detoxin D1 [MI]; (-)-Detoxin D1; L-Phenylalanine, N-(2-methyl-1-oxobutyl)-, (1S)-1-((2S,3R)-3-(acetyloxy)-1-((2S)-2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-2-carboxyethyl ester. CAS No. 37878-19-6. Molecular formula: C28H41N3O8. Mole weight: 547.64.
Detrothyronine
Detrothyronine is an analog of thyroxine. It has been used to reduce cholesterol in blood serum. Synonyms: 3,5,3'-Triiodo-D-thyronine; (2R)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid. Grade: >95%. CAS No. 5714-8-9. Molecular formula: C15H12I3NO4. Mole weight: 650.97.
Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases, which selectively binds to TYK2 pseudokinase (JH2) domain ( IC 50 =1.0 nM) and blocks receptor-mediated Tyk2 activation by stabilizing the regulatory JH2 domain. Deucravacitinib inhibits IL-12/23 and type I IFN pathways. Deucravacitinib, the FDA's world first de novo deuterium, is available for study in moderate to severe plaque psoriasis [1] [2]. Uses: Scientific research. Group: Isotope-labeled compounds. Alternative Names: BMS-986165. CAS No. 1609392-27-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-117287.
Deupirfenidone
Deupirfenidone-d 3 -d 3 is the deuterium labeled Pirfenidone (HY-B0673)[1]. Uses: Scientific research. Group: Isotope-labeled compounds. Alternative Names: LYT-100; AMR69-d3. CAS No. 1093951-85-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-B0673S1.
Deuruxolitinib
Deuruxolitinib, a deuterated Ruxolitinib (HY-50856), is an orally active JAK1 and JAK2 inhibitor. Deuruxolitinib demonstrates significant hair regrowth effects. Deuruxolitinib can be used for the research of alopecia areata [1]. Uses: Scientific research. Group: Isotope-labeled compounds. Alternative Names: CTP-543; Ruxolitinib d8; Deuterated Ruxolitinib. CAS No. 1513883-39-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-50856S.
Deutenzalutamide
Deutenzalutamide (Enzalutamide-d 3 ) is a developed deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells [1]. Uses: Scientific research. Group: Isotope-labeled compounds. Alternative Names: Enzalutamide-d3; MDV3100-d3. CAS No. 1443331-82-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-70002S.
Deuterated Poly(1,2-butadiene-d6), end-groups are deuterated
Deuterated Poly(1,2-butadiene-d6), end-groups are deuterated.
Deuterated Poly(1,2-butadiene-d6), end-groups are hydrogen-containing
Deuterated Poly(1,2-butadiene-d6), end-groups are hydrogen-containing.